Viewing StudyNCT06320717



Ignite Creation Date: 2024-05-06 @ 8:17 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06320717
Status: RECRUITING
Last Update Posted: 2024-05-06
First Post: 2024-03-13

Brief Title: AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-01-02
Start Date Type: ACTUAL
Primary Completion Date: 2026-07-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-07-02
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-13
First Submit QC Date: March 13 2024
Study First Post Date: 2024-03-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-03
Last Update Post Date: 2024-05-06
Last Update Post Date Type: ACTUAL